
    
      Study Objective: The primary objective of this study is to evaluate the efficacy of
      sclerotherapy with forced-air cooling during treatment.

      Study Design: This will be an investigator-initiated, evaluator-blinded,
      randomized-controlled, prospective, single-center clinical trial.

      Study Population: 20 evaluable subjects with bilateral lower extremity reticular and
      telangiectatic veins, who meet all study inclusion/exclusion criteria will be considered for
      entry into the study.
    
  